Are anti-diabetic drugs the silver bullet for the obesity epidemic? - Hospital Healthcare Europe

By A Mystery Man Writer

Beneficial weight loss induced by anti-diabetic medicines provides a much needed impetus in the fight against the global obesity epidemic.

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and

MedTech Pulse - Insights

June 1: Tracking Florida COVID-19 Cases, Hospitalizations, and Fatalities – Tallahassee Reports

Are anti-diabetic drugs the silver bullet for the obesity epidemic? - Hospital Healthcare Europe

How Wegovy, Ozempic, and Weight-Loss Drugs Could Break the Healthcare System - Barron's

Access & Quality of Healthcare

Views Archives - Page 2 of 7 - Hospital Healthcare Europe

Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?

Frontiers Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease

Nearly half of the U.S. population has diabetes or prediabetes—and many have no clue. Are you among them?

Cureus, Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges